| 000 | 01595 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515234904.0 | ||
| 264 | 0 | _c20110215 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/cncr.25518 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLoeb, David M | |
| 245 | 0 | 0 |
_aTandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. _h[electronic resource] |
| 260 |
_bCancer _cDec 2010 |
||
| 300 |
_a5470-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Neoplasms _xradiotherapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xadverse effects |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xadverse effects |
| 650 | 0 | 4 |
_aOsteosarcoma _xradiotherapy |
| 650 | 0 | 4 | _aRadiometry |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xadverse effects |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 700 | 1 | _aHobbs, Robert F | |
| 700 | 1 | _aOkoli, Amarachukwu | |
| 700 | 1 | _aChen, Allen R | |
| 700 | 1 | _aCho, Steve | |
| 700 | 1 | _aSrinivasan, Senthamizhchelvan | |
| 700 | 1 | _aSgouros, George | |
| 700 | 1 | _aShokek, Ori | |
| 700 | 1 | _aWharam, Moody D | |
| 700 | 1 | _aScott, Tammy | |
| 700 | 1 | _aSchwartz, Cindy L | |
| 773 | 0 |
_tCancer _gvol. 116 _gno. 23 _gp. 5470-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.25518 _zAvailable from publisher's website |
| 999 |
_c20051371 _d20051371 |
||